Context Therapeutics, Inc. (CNTX)
0.1891
-0.01
(-6.25%)
USD |
NASDAQ |
Oct 30, 16:00
0.1905
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Cash and Short Term Investments (Annual) : 66.00M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 66.00M |
| December 31, 2024 | 94.43M |
| December 31, 2023 | 14.45M |
| December 31, 2022 | 35.50M |
| Date | Value |
|---|---|
| December 31, 2021 | 49.64M |
| December 31, 2020 | 0.341M |
| December 31, 2019 | 0.2266M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Merck & Co., Inc. | 14.69B |
| EyePoint, Inc. | 306.09M |
| Neumora Therapeutics, Inc. | 182.53M |
| LENZ Therapeutics, Inc. | 292.35M |
| ANI Pharmaceuticals, Inc. | 294.75M |